Gillies Hunter

CIK 00018689971 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001868997

Recent Transactions

50 trades

Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-06-13−6,000→ 83,510 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-06-13$24.50/sh−6,000→ 5,602 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-06-13$2.14/sh+6,000→ 11,602 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-05-17−4,000→ 11,324 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-05-17$21.86/sh−86→ 5,602 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-05-17$2.14/sh+4,000→ 9,602 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-05-17$21.07/sh−3,914→ 5,688 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-04-17$23.33/sh−311→ 3,251 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-04-17$22.30/sh−3,689→ 3,562 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-04-17−503→ 2,511 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-04-17−3,497→ 539 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-04-17$1.74/sh+4,000→ 7,251 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-28$29.50/sh−9,000→ 3,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-03-28−9,000→ 89,510 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-28$2.14/sh+9,000→ 12,251 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-18$26.40/sh−613→ 3,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-03-18−4,000→ 4,036 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-03-18−3,000→ 98,510 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-18$25.81/sh−6,387→ 3,864 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-18$2.14/sh+3,000→ 10,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-18$1.74/sh+4,000→ 7,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-03-07−945→ 15,324 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-07$24.50/sh−8,975→ 3,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-07$2.14/sh+8,975→ 12,226 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-03-07−8,030→ 101,510 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-02-23$1.74/sh+511→ 3,762 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-02-23$19.50/sh−511→ 3,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-02-23−511→ 3,014 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-02-20−987→ 8,036 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-02-20$20.11/sh−2,591→ 4,149 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-02-20$1.74/sh+3,489→ 6,740 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-02-20−2,502→ 3,525 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-02-20$20.58/sh−898→ 3,251 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-01-22+66,586→ 66,586 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-01-17−4,000→ 6,027 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-01-17$1.74/sh+4,000→ 7,251 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-01-17$19.50/sh−4,000→ 3,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-27−25→ 16,269 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-27$24.50/sh−125→ 3,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-27−100→ 109,540 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-27$2.14/sh+125→ 3,376 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-20−1,076→ 10,027 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-20−2,924→ 9,023 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-20$19.50/sh−4,000→ 3,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-14−2,700→ 12,744 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-14$19.50/sh−9,897→ 3,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-14−7,197→ 10,306 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-14$1.74/sh+9,897→ 13,148 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-13$19.50/sh−2,103→ 3,251 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-13$1.74/sh+4,000→ 7,251 total

Companies

Jade Biosciences, Inc.
Chief Medical Officer
$JBIO

Recent Filings

Address

C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18

BOSTON, MA, 02116

View on SEC.gov